Cargando…
Impact of Metabolic Syndrome on Mortality and Morbidity After Coronary Artery Bypass Grafting Surgery
BACKGROUND: The prevalence of Metabolic syndrome (MetS) has been increased in Asian countries. It represents a cluster of cardiovascular risk factors including obesity, insulin resistance, lipid abnormality and hypertension. OBJECTIVES: The purpose of this study was to assess the association between...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Kowsar
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4253799/ https://www.ncbi.nlm.nih.gov/pubmed/25478548 http://dx.doi.org/10.5812/cardiovascmed.20270 |
_version_ | 1782347292074835968 |
---|---|
author | Ardeshiri, Maryam Faritus, Zahra Ojaghi-Haghighi, Zahra Bakhshandeh, Hooman Kargar, Faranak Aghili, Rokhsareh |
author_facet | Ardeshiri, Maryam Faritus, Zahra Ojaghi-Haghighi, Zahra Bakhshandeh, Hooman Kargar, Faranak Aghili, Rokhsareh |
author_sort | Ardeshiri, Maryam |
collection | PubMed |
description | BACKGROUND: The prevalence of Metabolic syndrome (MetS) has been increased in Asian countries. It represents a cluster of cardiovascular risk factors including obesity, insulin resistance, lipid abnormality and hypertension. OBJECTIVES: The purpose of this study was to assess the association between MetS and outcome in patients undergoing coronary artery bypass grafting surgery (CABG). PATIENTS AND METHODS: This prospective study was performed on patients scheduled for coronary artery bypass grafting surgery (CABG). All the patients were followed up in hospital and three months afterward. Patients were excluded if they were younger than 18 years or had severe comorbidities, a history of valvular heart disease, and low ejection fraction. RESULTS: A total of 235 patients (135 women) with a mean age of 59 ± 9.3 years were included. MetS was more prevalent in women (P < 0.001). The most prevalent complications were bleeding [20 (8.5%)] and dysrhythmia [18 (7.7%)]. At three months follow-up, the frequency rates of readmission [24 (10.2%)] and mediastinitis [9 (3.8%)] were higher than other complications. Diabetes and MetS were risk factors for a long ICU stay (> 5 days) and atelectasia (P < 0.05). Significant associations were observed between diabetes and pulmonary embolism (P = 0.025) and mediastinitis (P = 0.051). CONCLUSIONS: Identification of MetS before CABG can predict the surgery outcome. Patients with MetS have increased risks for longer ICU stay and atelectasia. |
format | Online Article Text |
id | pubmed-4253799 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Kowsar |
record_format | MEDLINE/PubMed |
spelling | pubmed-42537992014-12-04 Impact of Metabolic Syndrome on Mortality and Morbidity After Coronary Artery Bypass Grafting Surgery Ardeshiri, Maryam Faritus, Zahra Ojaghi-Haghighi, Zahra Bakhshandeh, Hooman Kargar, Faranak Aghili, Rokhsareh Res Cardiovasc Med Research Article BACKGROUND: The prevalence of Metabolic syndrome (MetS) has been increased in Asian countries. It represents a cluster of cardiovascular risk factors including obesity, insulin resistance, lipid abnormality and hypertension. OBJECTIVES: The purpose of this study was to assess the association between MetS and outcome in patients undergoing coronary artery bypass grafting surgery (CABG). PATIENTS AND METHODS: This prospective study was performed on patients scheduled for coronary artery bypass grafting surgery (CABG). All the patients were followed up in hospital and three months afterward. Patients were excluded if they were younger than 18 years or had severe comorbidities, a history of valvular heart disease, and low ejection fraction. RESULTS: A total of 235 patients (135 women) with a mean age of 59 ± 9.3 years were included. MetS was more prevalent in women (P < 0.001). The most prevalent complications were bleeding [20 (8.5%)] and dysrhythmia [18 (7.7%)]. At three months follow-up, the frequency rates of readmission [24 (10.2%)] and mediastinitis [9 (3.8%)] were higher than other complications. Diabetes and MetS were risk factors for a long ICU stay (> 5 days) and atelectasia (P < 0.05). Significant associations were observed between diabetes and pulmonary embolism (P = 0.025) and mediastinitis (P = 0.051). CONCLUSIONS: Identification of MetS before CABG can predict the surgery outcome. Patients with MetS have increased risks for longer ICU stay and atelectasia. Kowsar 2014-08-05 2014-08 /pmc/articles/PMC4253799/ /pubmed/25478548 http://dx.doi.org/10.5812/cardiovascmed.20270 Text en Copyright © 2014, Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences; Published by Kowsar. http://creativecommons.org/licenses/by-nc/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Ardeshiri, Maryam Faritus, Zahra Ojaghi-Haghighi, Zahra Bakhshandeh, Hooman Kargar, Faranak Aghili, Rokhsareh Impact of Metabolic Syndrome on Mortality and Morbidity After Coronary Artery Bypass Grafting Surgery |
title | Impact of Metabolic Syndrome on Mortality and Morbidity After Coronary Artery Bypass Grafting Surgery |
title_full | Impact of Metabolic Syndrome on Mortality and Morbidity After Coronary Artery Bypass Grafting Surgery |
title_fullStr | Impact of Metabolic Syndrome on Mortality and Morbidity After Coronary Artery Bypass Grafting Surgery |
title_full_unstemmed | Impact of Metabolic Syndrome on Mortality and Morbidity After Coronary Artery Bypass Grafting Surgery |
title_short | Impact of Metabolic Syndrome on Mortality and Morbidity After Coronary Artery Bypass Grafting Surgery |
title_sort | impact of metabolic syndrome on mortality and morbidity after coronary artery bypass grafting surgery |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4253799/ https://www.ncbi.nlm.nih.gov/pubmed/25478548 http://dx.doi.org/10.5812/cardiovascmed.20270 |
work_keys_str_mv | AT ardeshirimaryam impactofmetabolicsyndromeonmortalityandmorbidityaftercoronaryarterybypassgraftingsurgery AT farituszahra impactofmetabolicsyndromeonmortalityandmorbidityaftercoronaryarterybypassgraftingsurgery AT ojaghihaghighizahra impactofmetabolicsyndromeonmortalityandmorbidityaftercoronaryarterybypassgraftingsurgery AT bakhshandehhooman impactofmetabolicsyndromeonmortalityandmorbidityaftercoronaryarterybypassgraftingsurgery AT kargarfaranak impactofmetabolicsyndromeonmortalityandmorbidityaftercoronaryarterybypassgraftingsurgery AT aghilirokhsareh impactofmetabolicsyndromeonmortalityandmorbidityaftercoronaryarterybypassgraftingsurgery |